Intensive Care Unit
Original Article
/ VOLUME 4, ISSUE 4, DECEMBER 2022
Hande Özportakal and others
The world has been fighting against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than two years, leading to more than 605 million cases and 6.4 million deaths as of September 11, 2022. Since the angiotensin-converting enzyme (ACE) is the functional receptor for SARS-CoV-2, predominantly expressed by the alveoli (...) Read More
Original Article
/ VOLUME 4, ISSUE 4, DECEMBER 2022
Hasan Naz and others
Nosocomial infections (NIs) constitute a major health issue in terms of morbidity, high mortality, prolonged hospitalization, and increased costs of direct patient care. While beds in intensive care units (ICUs) constitute less than 10% of all hospital beds, more than 20% of all NIs develop in the ICU. The human lifespan has been prolonged (...) Read More
Original Article
/ VOLUME 4, ISSUE 1, MARCH 2022
Mehmet Kürşat Bilgin and others
Fungal infections account for about 20% of all microbiological infections in critically ill patients. Candida species are the most common fungi in intensive care units (ICU) and mostly C. albicans. However, the rate of non-albicans Candida species such as C. tropicalis, C. krusei, C. parapsilosis, C. glabrata which are more resistant to antifungal therapy (...) Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Aral Sürmeli and others
Introduction The novel coronavirus (SARS-CoV-2) started in December 2019 in China, has infected over 4.2 million people worldwide, resulting in a death toll of 290 000 as of 13 May 2020 (1). It causes a multi-systemic infection named Coronavirus Disease 2019 (COVID-19). The symptoms reported are Read More